Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Alberta confirms blood clot disorder death linked to AstraZeneca vaccine

05/05/2021 | 12:54am EDT

EDMONTON — An Alberta woman in her 50s has died from a rare blood clot disorder after receiving the Oxford-AstraZeneca COVID-19 vaccine.

The province's chief medical officer of health confirmed in a statement the death linked to vaccine-induced immune thrombotic thrombocytopenia or VITT.

Dr. Deena Hinshaw says the fatality is the second VITT case and only death related to VITT out of more than 253,000 doses of AstraZeneca that have been administered in Alberta to date.

Hinshaw says while any death is tragic, "it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine."

She notes the global risk of developing VITT has been estimated at approximately one case in 100,000 to 250,000 doses of vaccine.

In comparison, Albertans between the ages of 50 and 59 who are diagnosed with COVID-19 are 350 times more likely to die from that infection than to experience VITT after an AstraZeneca shot.

Hinshaw says that age group is also at least 1,500 times more likely to be hospitalized from COVID-19 than experiencing VITT after getting AstraZeneca.

This report by The Canadian Press was first published May 4, 2021.

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

All news about ASTRAZENECA PLC
05:31pProvinces look to mix COVID-19 vaccines in light of changing supply
AQ
12:13pASTRAZENECA  : Delivers 50 Million COVID-19 Vaccines To EU
MT
12:12pASTRAZENECA  : reaches vaccine shipping milestone as EU sues again
RE
11:37aASTRAZENECA  : finally reaches vaccine shipping milestone to EU that was due in ..
RE
11:11aASTRAZENECA  : EU to launch new legal action against AstraZeneca over vaccine de..
RE
10:58aTHE LATEST : Japan to purchase antibody cocktail for COVID-19
AQ
10:58aGLOBAL MARKETS LIVE : Coty, Marriott, Tyson Foods, Traton, Ford...
09:54aASTRAZENECA  : Italian Region Pushes Population to Go For AstraZeneca, Johnson &..
MT
09:43aAMGEN  : Says AstraZeneca Files Biologics License Application for Severe Asthma ..
MT
09:39aASTRAZENECA  : EU insists dispute with AstraZeneca is only contractual
AQ
More news
Financials (USD)
Sales 2021 30 843 M - -
Net income 2021 4 552 M - -
Net Debt 2021 11 038 M - -
P/E ratio 2021 29,9x
Yield 2021 2,62%
Capitalization 143 B 143 B -
EV / Sales 2021 5,00x
EV / Sales 2022 4,45x
Nbr of Employees 76 100
Free-Float 95,8%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 130,16 $
Last Close Price 109,02 $
Spread / Highest target 52,2%
Spread / Average Target 19,4%
Spread / Lowest Target -12,7%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC5.37%142 034
JOHNSON & JOHNSON8.19%443 727
ROCHE HOLDING AG-1.88%289 958
PFIZER, INC.7.53%220 784
ABBVIE INC.8.46%204 279
MERCK & CO., INC.-4.44%198 539